Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Smart Nanoparticles

Financiado

4D Brain-Targeting Nanomedicines for Treating Neurodegeneration

Aging, Aging, genetic, and environmental factors have increased the prevalence of patients with neurodegenerative brain conditions, with limited treatment modalities. One prerequisite for effective brain treatments is the ability... ver más

30/04/2028

TECHNION ISRAEL I...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

TECHNION ISRAEL INSTITUTE OF TECHNOLOGY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-04-20

ERC-2022-COG: ERC CONSOLIDATOR GRANTS Scope:Objectives

I+D

Cerrada hace 2 años

0% 100% 100%

1 Participantes

TECHNION ISRAEL INSTITUTE O...

2.00M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2019-105531RB-I00 NANOTRANSPORTADORES LIPIDICOS FUNCIONALIZADOS CON CANNABIDIO... 109K€ Cerrado

PID2021-127983OB-C22 EVALUACION IN VITRO E IN VIVO DE NUEVOS NANOPORTADORES PARA... 104K€ Cerrado

RTI2018-098027-B-C22 ESTUDIOS IN VITRO E IN VIVO DE NUEVOS NANOVEHICULOS PARA TER... 73K€ Cerrado

CTQ2017-89588-R NANOCAPSULAS BIOMIMETICAS PARA LA ADMINISTRACION DIRIGIDA DE... 71K€ Cerrado

PID2021-124363OA-I00 NANOPARTICULAS CAMUFLADAS CON MEMBRANAS CELULARES PARA TERAP... 157K€ Cerrado

RTI2018-098027-B-C21 NUEVOS NANOVEHICULOS PARA TERANOSTICA DE ENFERMEDADES CEREBR... 151K€ Cerrado

Duración del proyecto: 60 meses Fecha Inicio: 2023-04-20
Fecha Fin: 2028-04-30

Líder del proyecto

TECHNION ISRAEL INSTITUTE OF TECHNOLOGY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto Aging, Aging, genetic, and environmental factors have increased the prevalence of patients with neurodegenerative brain conditions, with limited treatment modalities. One prerequisite for effective brain treatments is the ability to target next-generation medications, including RNA and protein drugs, to specific neurons and brain regions. Nanotechnology platforms offer new therapeutic avenues for targeting drugs to organs and cells; their implementation in neurodegenerative diseases is nascent. In this research program, we aim to advance far beyond the state-of-the-art and elucidate the molecular and structural characteristics for designing nanotechnology drugs that target and treat brain neurodegeneration. In preliminary studies, we show that the blood-brain-barrier (BBB) overexpresses disease-specific receptors during neurodegeneration, which enable targeted nanoparticles to cross the BBB and penetrate neurons. Albeit these findings, the magnitude, mechanism, and nanotechnological molecular pattern for brain targeting are lacking. To address this fundamental gap, we will use advanced computation and engineering concepts to develop 4D-brain-targeting nanoparticles, that cross the BBB intact to target specific neuronal populations and brain regions. Robotic synthesis, coupled with active learning algorithms will be used to construct nanoparticles with combinations of targeting moieties on their surface and evaluate their neuronal specificity. Supported microfluidic BBB apparatus will be used to screen the nanoparticles’ ability to target and cross the BBB. A track-and-seek radar system will locate the nanoparticles in the brain, directing localized robotic biopsy of the nanoparticles in the destination cells in the brain. To connect our findings to future clinical implementation, fMRI will be used to record the therapeutic activity of the nanoparticles in the brain. This program will provide the community with essential findings to allow brain-targeted therapeutics.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores